Gapping up
In reaction to strong earnings/guidance: DSCO +15.4% (also provides update on Surfaxin; says progress on addressing sole remaining issue to gain potential FDA approval in 2011 of Surfaxin), ISSI +11.9%, OC +9.1%, MPEL +5.9%, BIN +4.7%, SIMG +4.7%, GT +4.3%, RFMD +3.1%, GLW +2.9%, RDS.A +2.5%, TMO +2.5% (light volume), BRCM +2.4%, KTCC +2.3%, LIFE +1.7%, DOW +1.4%, AFL +1.1%, DWA +1.0%.
Select financial related names rebounding: NBG +7.7%, AIG +2.4%, KEY +1.5%, C +1.4%, GS +1.0%.
Select casino names trading higher: WYNN +2.2%, MGM +2.1%, LVS +2.0%.
Other news: SURG +56.8% (Synergetics USA enters into a settlement and license agreement with Alcon), CIIC +22.1% (still checking), CSII +10.5% (receives unconditional FDA approval for ORBIT II coronary clinical trial), MRNA +8.1% (Announces Combinations of UsiRNAs in Proprietary DiLA2 Delivery Technology Show Improved Efficacy in Bladder Cancer Model ), AVII +7.7% (secures increased funding of approx $4.0 mln), CTAS +6.2% (light volume; announced the appointment of Joe Scaminace to its board of directors. Scaminace is the Chairman, President and CEO of the OM Group), DVAX +1.3% (Dynavax Technologies Two Phase 3 HEPLISAV Trials Cleared by DSMB to Continue Immunizations), SYT +1.3% (entered into a long-term multi-crop partnership with Embrapa).
Analyst comments: SQNM +4.6% (upgraded to Buy from Neutral at Global Hunter), TLAB +3.1% (upgraded to Overweight from Neutral at JP Morgan), BRCD +2.2% (upgraded to Outperform from Sector Perform at RBC Capital), NVAX +1.9% (initiated with a Buy at Lazard), , ACE +0.6% (upgraded to Buy from Hold at Citigroup).
Gapping down
In reaction to disappointing earnings/guidance: BWLD -20.0% (also downgraded to Perform from Outperform at Oppenheimer), HTCH -19.6%, JST -14.0%, AMAG -13.0%, CCUR -10.1%, RHI -10.0% (also downgraded to Neutral at Robert W. Baird), CNXT -8.9%, PMTC -6.5%, MTW -6.5%, WBSN -6.2%, S -5.9%, SMCI -5.2%, FLEX -4.9%, AMKR -4.8%, JBLU -4.1%, AOL -3.1%, PNRA -3.0%, FPFC -2.8%, SAP -1.8%, RCL -1.0%.
Select financial related names showing weakness: AIB -5.9%, STD -1.7% (trading ex dividend), IRE -1.0%.
Other news: MTA -11.8% (trading ex dividend), TTM -3.8% (still checking), WPPGY -3.5% (still checking for anything specific), CCL -2.4% (down in sympathy with RCL), PNC -2.2% (Treasury Department announces public offering of warrants to purchase common stock of PNC), VOD -1.5% (still checking), WY -1.4% (trading ex dividend; also downgraded to Underperform from Neutral at Credit Suisse), AINV -1.2% (prices public offering of common stock at $12.40).
Analyst comments: F -1.4% (downgraded to Underperform from Neutral at Credit Suisse), DELL -1.4% (downgraded to Neutral from Buy at UBS), MOT -1.2% (downgraded to Sector Perform from Outperform at RBC Capital).